This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Medical technology analyst David Roman rates GE HealthCare a buy and believes its 2% guidance for 2Q and 3Q growth underestimates a strong U.S. Medical technology analyst David Roman rates GE HealthCare a buy and believes its 2% guidance for 2Q and 3Q growth underestimates a strong U.S.
Jason Scharton : You know, it it, it Cole, it does come down to because when we look at personal safety at three M, we’re looking at, we’ve got one group who works on that for all industries around the world, whether it be, you know, medical or industrial or, or consumer. I’ll start with Jason.
Richie is here to talk about how offering comprehensive health benefits like medical, dental and vision coverage and much more can have a tremendous impact on both your employees well being and your business. Medical, dental, vision. I want to do the most amount that I can for my guys and make sure they’re taken care of.
I watched in awe for nearly 25 years as Bernie envisioned groundbreaking philanthropic responses to social and medical challenges. He is vice chairman and co-head of investment banking at TM Capital, a division of Janney. To me, the common thread running through his philanthropy was Bernie’s heart. What a life! Success.
A deeper dive into the profile of a PCBA manufacturer, with a 60% customer operating in the medical device market, may have less risk than first appears. Diversify sales across industry verticals (automotive, defense, telecom, medical etc.). Consider diversification by acquisition (product mix, customers, geography etc).
Brad joins us with over a decade of investment banking experience, having advised on more than 30 middle-market M&A transactions across healthcare, consumer, and industrial sectors.
Pharmaceutical companies also are investing heavily in AI-driven solutions to optimize their drug development processes, particularly by leveraging AI platforms to analyze vast datasets and accelerate discovery. The FTC nevertheless has remained focused on the life sciences/medical device sector in other parts of its enforcement efforts.
"JNJ is a stable, defensive grower with the industry's strongest balance sheet allowing for continued high [return on invested capital] investments in the Innovative Medicines segment to augment revenue growth," Goldman said in a May report. billion, including $300 million of anticipated cash tax benefits.
I watched in awe for nearly 25 years as Bernie envisioned groundbreaking philanthropic responses to social and medical challenges. He is vice chairman and co-head of investment banking at TM Capital, a division of Janney. To me, the common thread running through his philanthropy was Bernie’s heart. What a life! Success.
PE firms investing domestically —far surpassing the number of outbound (89) and inbound (27) transactions, a sign of confidence in American manufacturing resilience. Healthcare Manufacturing Stands Out Two subsectors— Pharmaceutical Manufacturing and Medical Devices & Supplies —are drawing particularly deep interest.
The medical device maker has topped bottom-line estimates 88% of the time, with its stock averaging a 2.5% Deutsche Bank's $70 price target implies potential upside of about 31% for Chipotle over the next 12 months. Intuitive Surgical is another company reporting next week with a history of beating earnings expectations.
With a diversified portfolio, a focus on premium segments and notable investment from Berkshire Hathaway, STZ may be poised for a rebound. Its beer portfolio, including powerhouse brands like Modelo and Corona, aligns with the +2% volume growth in premium beer observed in 2024.
Shares kicked off the week with a drop of almost 14% on Monday after the company said that it's going to buy a bioscience and diagnostics unit that was spun off from medical technology company Becton Dickinson for $17.5 That adds to its sizable losses in recent months, as the stock has fallen nearly 29% in the last six.
Yet, behind the scenes, it’s one of the most active areas of investment , particularly over the past two years. PE firms investing in domestic companies. Medical Equipment and Supplies Manufacturing From surgical instruments to diagnostic devices, this sector is central to modern healthcare delivery.
Hopefully, states and school communities are able to rebound from the shock and recommit to these critical student needs and district investments. Here is a breakdown of top near-term spending priorities: Faculty and staff salaries , driven by combination of new hires, incentives, and bargained agreements.
DSO Creation Private equity investment in dental practices began in the 1990’s when the first DSOs sought outside investors. Investing activity in subspecialties including orthodontics, endodontics, and pediatric dentistry further amplified deal volumes. Second, some of the younger DSOs are in an initial growth phase.
*UPDATE* Oregon Senate Bill 951, described in the alert below originally published on May 30, 2025, was signed into law by Oregon Governor Tina Kotek on Monday, June 9, and will apply to all new investments beginning January 1, 2026, and all investments effective January 1, 2029. By: Goodwin
This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. By: FOCUS Investment Banking Please see full Article below for more information.
Marena , founded in 1994 and based in Lawrenceville, Georgia, is a manufacturer of medical-grade compression garments, specializing in post-surgical recovery solutions for invasive and non-invasive surgeries, mastectomy, maternity and post-pregnancy, and lipedema. Terms of the transaction were not disclosed.
The post LMP invests in medical billing service ACU-Serve appeared first on PE Hub. Jim Knight, founder and CEO of ACU-Serve, will continue to lead ACU-Serve.
The investment will be used to back Bluesight's acquisition of Medacist, a drug diversion monitoring firm. The post Thoma Bravo invests in medication intelligence firm Bluesight appeared first on PE Hub.
Ascend Capital's majority investment in Seoul Medical Group; SK Capital's deal with Milestone Environmental Services; and Excellere Partners' two-asset continuation fund deal.
The investment will be used to enable OnPoint to accelerate its product development roadmap, bolster its sales and marketing efforts, and strengthen the company’s customer service. The post Peloton Equity and Fort Maitland Capital invest in medical tech company OnPoint appeared first on PE Hub.
The post Medical staffing agency Hardenbergh Group secures investment from BV appeared first on PE Hub. Silvermark Partners LLC served as financial advisor to Hardenbergh Group on the deal.
When the deal closes, the combined company will operate as Baird MedicalInvestment Holdings Limited and be listed on the NASDAQ under the new ticker symbol "BDMD." The post Chinese medical tech firm Baird Medical to go public via merger with PE-backed SPAC ExcelFin appeared first on PE Hub.
Charac secures £1M investment from world-class medication platform MedAdvisor to drive its International growth Total capital raised by Charac now sits at £3.5
The post NMS invests in medical case management services firm VONA Case Management appeared first on PE Hub. Bailey & Company served as financial advisor to VONA on the deal.
Edwards Lifesciences recently announced that it would acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (“TMVR”) company. Edwards had the option to acquire Innovalve following an initial investment in 2017. The acquisition is expected to close by the end of the year. By: Knobbe Martens
The post Stone Point Capital invests in medical stop-loss captive platform ClearPoint appeared first on PE Hub. ClearPoint is led by CEO Jeb Dunkelberger.
Based on the large number of medical practices acquired over the past decade, you may think selling your practice is a routine process. By: FOCUS Investment Banking
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. By: FOCUS Investment Banking But that’s been changing over the past few years and is likely to continue to grow moving forward. Please see full Publication below for more information.
Other than the US and India, there is no other country attracting the numbers of VC investment in the sector. It invests in early-stage companies in software, SaaS, healthcare, fintech, security and media. Its UK funds primarily invest at Series A through to Series C, and typically lead rounds with cheques between £2m and £10m.
Vancouver-based ProShop provides software to manufacturers in regulated industries such as the defense, aerospace, medical and space industries. The post Mainsail Partners makes growth equity investment in ProShop ERP appeared first on PE Hub.
In this industry, owning 50 to 100 or more veterinary centers gives you procurement advantages in that you can buy much higher volumes of suppliers (syringes, medical equipment, etc.) investment banking, private equity , VC, etc.) and thus receive volume discounts with better pricing. and how our process works.
Founded in 2017, Travel Buggy distributes its brand of power wheelchairs online and through a network of over 300 home medical stores. The post KV Capital invests in power wheelchair provider Travel Buggy appeared first on PE Hub.
was the exclusive financial advisor to eMedApps in its strategic merger with Medical Technology Solutions, LLC, a Sunstone Partners backed healthcare managed services company. Medical Technology Solutions (“MTS”) was founded in 2006 with headquarters in Valencia, California. They are a certified NextGen consultant.
Rising prevalence of chronic diseases and Research & Development (R&D) investments and rising number of healthcare professionals, and technological advancements in medical pendants are key factors driving medical pendant market revenue growth Rising prevalence of chronic diseases and Research & Development (R&D) investments and rising (..)
This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. a physician was out on medical leave) and similar matters. Eric Yetter is an investment banker focused on healthcare. appeared first on FOCUS Investment Banking LLC.
Increasing investments in enhanced surgical planning and training and patient education and communication is a key factor driving Medical Holography market revenue growth.
In the ever-evolving medical supplies market, North America maintains its dominant position. However, Europe and Asia-Pacific are swiftly advancing, propelled by growing healthcare investments and rising demand for medical supplies, marking a transformative shift in the industry
Westford, USA, July 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Medical Devices market will attain a value of $756.59 Medical devices are essential tools used in the healthcare sector to diagnose and monitor medical conditions. Billion by 2031, with a CAGR of 5.8% over the forecast period (2024-2031).
Increasing investments of different pharmaceutical and cosmetic companies is a key factor driving 3D printing medical devices market revenue growth. Increasing investments of different pharmaceutical and cosmetic companies is a key factor driving 3D printing medical devices market revenue growth.
SkyQuest projects that the Asia medical/hospital beds market will attain a value of USD 904.35 Medical and hospital beds are essential for the chronically ill and elderly populations. SkyQuest projects that the Asia medical/hospital beds market will attain a value of USD 904.35 million by 2030, with a CAGR of 5.8%
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content